Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$5.92 - $8.6 $444,000 - $645,000
75,000 Added 39.54%
264,700 $1.74 Million
Q2 2024

Aug 14, 2024

BUY
$7.35 - $10.05 $1.17 Million - $1.6 Million
159,700 Added 532.33%
189,700 $1.42 Million
Q1 2024

May 15, 2024

BUY
$9.13 - $15.52 $45,650 - $77,600
5,000 Added 20.0%
30,000 $299,000
Q4 2023

Feb 14, 2024

BUY
$5.09 - $10.79 $127,250 - $269,750
25,000 New
25,000 $246,000

Others Institutions Holding RXRX

About RECURSION PHARMACEUTICALS, INC.


  • Ticker RXRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 180,480,000
  • Market Cap $1.16B
  • Description
  • Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...
More about RXRX
Track This Portfolio

Track Caption Management, LLC Portfolio

Follow Caption Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Caption Management, LLC with notifications on news.